 |
|
|
| |
Expected 8-Week Prenatal vs 12-Week Perinatal TAF Prophylaxis to Prevent HBV-MTCT: A Multicenter, Prospective, Open-label, Randomized Controlled Trial
|
| |
| |
AASLD 2024 Nov 15-19 San Diego
Qing-Lei Zeng, M.D., Ph.D.
Department of Infectious Diseases and Hepatology,
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China November 18, 2024 San Diego, CA, USA
|
| |
|
|
|
|
|
